Dr. Karl Lintner, a legendary scientist and pioneer of peptide beauty technology, became the chief scientific advisor to the US (02145) Scientific Committee

The Zhitong Finance App learned that in August, Shanghai US shares (02145), which had just announced high performance growth in the first half of the year, made another major move. Yesterday, Shangmei Co., Ltd. officially announced that Dr. Karl Lintner (hereinafter referred to as Dr. Lintner), the pioneer of global peptide beauty technology, has officially become the chief scientific advisor of the Shanghai American Scientific Committee.

This heavyweight multinational research cooperation not only marks a new critical stage in the global R&D strategic layout with the US, but also injects world-class momentum into Chinese peptide research and the development of the Chinese beauty industry using the model of global scientific research intelligence+local transformation in China.

The first person in the world to join peptide beauty, and the US research team welcomed international leaders

As the “founder of peptide technology” for modern effective beauty, Dr. Lintner is an authority figure in the global cosmetic science community. He has a doctorate degree in biochemistry from the University of Vienna, Austria, and has accumulated ten years of experience in biopeptides in the early days at the Saclay Nuclear Research Center in France. His research career has always been closely linked to industry innovation. His core achievement was to successfully introduce patented peptide technology into the cosmetic application field for the first time, completely revolutionizing the development trajectory of global beauty technology.

Prior to that, the application of “peptides” in the beauty industry was limited to the field of biopharmaceuticals, and Dr. Lintner successfully introduced this ingredient into cosmetic research and development for the first time through efforts, making “peptides” officially an important raw material for scientific cosmetics development, and establishing a trinity system of “active ingredient development - industrial transformation - global standard setting”.

In the context of global beauty companies competing for research resources, Dr. Lintner chose to join the US. It was not an accident, but stemmed from deep resonance with the brand's research strategy and global vision.

As a leading domestic beauty company, the US has already established a scientific research framework to support international cooperation — the US Scientific Committee. By integrating the world's top resources and promoting open innovation, it has built a truly interdisciplinary and borderless scientific research community. It is the strategic core driving the Group to achieve global technological leadership and transformation power in the Chinese market. This fits perfectly with Dr. Lintner's important mission to achieve scientific value implementation.

More importantly, the vitality of the Chinese beauty market and the uniqueness of the US as a leader in domestic products also provided a broad verification scenario for Dr. Lintner's choices. On the one hand, Chinese consumers' demand for effective products continues to escalate, driving enterprises to accelerate technological iteration; on the other hand, the US has become a powerful platform for connecting technological breakthroughs with consumer demand, based on a multi-brand matrix and deep market roots.

Rooted in the conceptual consensus between the two sides, Dr. Lintner believes that the “global technology+local insight” two-wheel drive model provides unprecedented depth and breadth for peptide science from the laboratory to the global market. It will also help the US enhance its voice in the global cosmetics field, promote innovative achievements originating in China to the world, and truly realize the vision of “gathering world scientific research and serving Chinese brands”.

After 20+ years of deep cultivation in the peptide field, Han Shu's key leapfrog to the leading position in the industry

As one of the world's recognized anti-aging giant ingredients, peptides were introduced into the skincare field by major international brands half a century ago, yet domestic brands have not actually entered this core competitive circuit, and anti-wrinkle ingredients still rely on imports and imitation.

In this long scientific research competition, Han Shu spent 20+ years of continuous investment to gradually build a scientific research moat that is difficult to replicate.

In 2003, Han Shu focused on peptide components and related technologies for the first time; by 2016-2018, the Chinese and foreign research centers of Shangmei Co., Ltd. were established, officially entering the stage of self-development and innovative application of raw materials in the field of peptides; by 2018-2022, Han Shuhong Capsule Polypeptide Water, Blue Copper Peptide Series, etc. were introduced, and Chinese companies gradually synchronized with foreign-funded enterprises in the application of peptide raw materials.

Adhering to the concept of “technology without borders”, Han Shu relied on Shangmei Co., Ltd. to recruit international scientific research talents, thoroughly analyzed and studied peptides, successfully invented various combination peptides, and took the lead in formulating the industry's first peptide group standard. In April 2024, Cyclic Hexapeptide-9, which had been accumulated over many years of scientific research, successfully passed the new raw material registration, marking Han Shu's official entry into a new stage of innovative peptide research and development, setting a benchmark for independent innovation in the field of anti-aging for domestic cosmetics.

After more than 20 years of accumulation, Han Shu has gone through a long process of understanding peptides, analyzing peptides, and researching peptides to innovating peptides, and has worked hard in the field of “peptide” anti-aging, so that domestic beauty products can overtake overseas brands in this field.

Dr. Lintner's addition this time will be another key leap forward in the US's global peptide technology layout. It is reported that Dr. Lintner's cooperation is not short-term, but rather a long-term layout of the US's global R&D strategy. According to the plan, it will assume three core roles:

The first is a technological breakthrough. Dr. Lintner will provide forward-looking plans for the global peptide technology layout in the US and provide technical suggestions and solutions for the research team. The second is ecological construction. As the core promoter of the global research ecosystem in the US, Dr. Lintner helps connect with top international research institutions and academic organizations. The third is resource integration, leading the establishment of a multinational R&D cooperation platform to achieve the sharing and collaborative innovation of high-quality global scientific research resources.

Global wisdom and local transformation, the professional era of domestic beauty products is coming

For domestic cosmetics, which are undergoing a transformation from a simple scale expansion to an era of beauty expertise in China, Dr. Lintner's joining has strategic significance far exceeding that of a single enterprise. It marks that China's beauty research is entering a new stage of systematic competitiveness construction. From an industry perspective, this collaboration brought at least two major breakthroughs:

The first is to deepen the global R&D model: from passive introduction to active collaboration.

In the past, international R&D by Chinese beauty companies was mostly limited to setting up laboratories and purchasing technology patents overseas, and this cooperation between the Shanghai American Scientific Committee deepened the deep participation of top international scientists in corporate strategic planning.

Dr. Lintner will push the US to connect with top international research institutions, establish a multinational R&D cooperation platform, cooperate with top domestic medical institutions through the Han Shu Translational Medicine Foundation, and cooperate with top domestic medical institutions through the Han Shu Translational Medicine Foundation, so that “global technology” can truly meet “Asian skin needs.” This active collaboration model will help beauty companies in the US and China break out of the dilemma of following technology, accelerate the construction of a globally competitive R&D system, and achieve overtaking corners.

The second is to lead the establishment of industry standards: the global voice of Chinese beauty is rising at an accelerated pace.

Empowered by Dr. Lintner's international perspective, the US will promote the establishment of a “Chinese Original Ingredient” certification system to promote breakthroughs in peptide technology, green synthesis, etc., accelerate the construction of R&D sovereignty, data sovereignty, and standard sovereignty, and set a new benchmark at the level of quality standards and standard setting. This means that in the future, Chinese beauty companies will not only be able to export products, but also technical standards, achieve transformation from technology followers to standard setters, and continue to enhance the international voice of the scientific research system.

As can be seen, the “global scientific research era” of Chinese beauty has arrived. When the world's top scientists choose to build a research ecosystem with Chinese companies, and when global wisdom forms a synergy with China's transformation, domestic beauty products can not only bring more efficient skincare solutions to consumers, but also gradually occupy an important position in the global beauty research landscape.

As Dr. Lintner said, “Science knows no borders. Only by sharing global technology and talent can cutting-edge technology benefit global consumers.” And this shared beauty is probably the core meaning of the US and even Chinese beauty going global.